Florida this week became a major focus for advocates on both main sides of the abortion debate.
Chinese drugmaker receives FDA warning letter after management hindered inspection
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS